| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada74fa55a7e013b241d81ef5dd21f0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22dd2fabe5d349a67dbb88ebda6d3c41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 |
| filingDate |
2009-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e74675ef969f01de0a2bb4ece024f60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d4e322daaf0f929ec375c16634c48cb |
| publicationDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011295018-A1 |
| titleOfInvention |
Process for the manufacture of an intermediate in the synthesis of dabigatran |
| abstract |
The invention relates to a process for the synthesis of the diamine of formula (1) an important intermediate in the synthesis of dabiagtran etexilate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011123635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011129538-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011118471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8471033-B2 |
| priorityDate |
2008-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |